Figure 9
Renal mRNA expression of (A) endothelial-converting enzyme (ECE), (B) ET-1, the ET receptors, (C) ETA receptor (ETA R) and (D) ETB receptor (ETB R), and (E) Western blot of ETA R and ETB R and (F–G) their quantification relative to β-actin, respectively, following treatment with vehicle, sunitinib (14 mg/kg/day; SU) alone or during co-treatment with low-dose aspirin (COX-1 inhibition, 5 mg/kg/day; SU+low-dose A) or high-dose aspirin (dual COX-1 and COX-2 inhibition, 100 mg/kg/day; SU+high-dose A). Renal mRNA expression is normalised to the internal housekeeping gene, Hprt1, and is expressed relative to the vehicle-treated group. Data are presented as mean ± SEM (n=5–7/group). Data were analysed using a one-way ANOVA.
The effect of treatment on renal expression of components of the endothelin (ET) system

Renal mRNA expression of (A) endothelial-converting enzyme (ECE), (B) ET-1, the ET receptors, (C) ETA receptor (ETA R) and (D) ETB receptor (ETB R), and (E) Western blot of ETA R and ETB R and (F–G) their quantification relative to β-actin, respectively, following treatment with vehicle, sunitinib (14 mg/kg/day; SU) alone or during co-treatment with low-dose aspirin (COX-1 inhibition, 5 mg/kg/day; SU+low-dose A) or high-dose aspirin (dual COX-1 and COX-2 inhibition, 100 mg/kg/day; SU+high-dose A). Renal mRNA expression is normalised to the internal housekeeping gene, Hprt1, and is expressed relative to the vehicle-treated group. Data are presented as mean ± SEM (n=5–7/group). Data were analysed using a one-way ANOVA.

Close Modal

or Create an Account

Close Modal
Close Modal